Mesoblast Limited (MESO) P/S ratio
Mesoblast Limited (MESO) trades at 12.8× its revenue per share for fiscal 2026. At the end of fiscal 2026 (June 30, 2026) its P/S ratio was 14.6×. That is 80.9% lower than the 76.5× of fiscal 2025. Figures as of 18 Nov 2026, 10:46 UTC, from Yahoo Finance.
Key facts
- P/S ratio today
- 12.8×
- P/S ratio, fiscal 2026
- 14.6×
- Change on fiscal 2025
- −80.9%
- Highest on record
- 113.9×fiscal 2024
- Lowest on record
- 14.6×fiscal 2026
- Fiscal years on record
- 42023–2026
Figures as of . Statements from Yahoo Finance. Figures, not advice.
Mesoblast Limited P/S ratio, in more detail
Today's figure is 12.0% below the fiscal 2026 year-end.
Across the 4 fiscal year-ends on record (2023–2026), the highest was 113.9× in fiscal 2024 and the lowest 14.6× in fiscal 2026. Today's P/S ratio is at or below every one of the 4 fiscal year-ends on record; their median is 78.8×.
P/S ratio at each fiscal year-end
The last point is today's figure; the others are fiscal year-ends.
Mesoblast Limited P/S ratio, year by year
| Fiscal year | P/S ratio | Change | Year ended | Share price at year-end | Revenue per share |
|---|---|---|---|---|---|
| Today | 12.8× | — | $11.91 | — | |
| 2026 | 14.6× | 80.9% down | $13.53 | $0.93 | |
| 2025 | 76.5× | 32.8% down | $10.89 | $0.14 | |
| 2024 | 113.9× | 40.4% up | $6.81 | $0.06 | |
| 2023 | 81.1× | — | $7.82 | $0.10 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.
How to read it
It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.
Mesoblast Limited, figure by figure
- Mesoblast Limited market cap
- Mesoblast Limited revenue
- Mesoblast Limited earnings
- Mesoblast Limited earnings per share (EPS)
- Mesoblast Limited P/E ratio
- Mesoblast Limited P/B ratio
- Mesoblast Limited free cash flow
- Mesoblast Limited operating margin
- Mesoblast Limited dividend
- Mesoblast Limited shares outstanding
- Mesoblast Limited total debt
- Mesoblast Limited cash on hand
- Mesoblast Limited total assets
- Mesoblast Limited return on equity (ROE)
- Mesoblast Limited return on invested capital (ROIC)
Mesoblast Limited (MESO) overview: price, valuation and scorecard
Mesoblast Limited P/S ratio: questions and answers
What is Mesoblast Limited's P/S ratio?
Mesoblast Limited (MESO) trades at 12.8× its revenue per share for fiscal 2026. At the end of fiscal 2026 (June 30, 2026) its P/S ratio was 14.6×. That is 80.9% lower than the 76.5× of fiscal 2025.
Is Mesoblast Limited's P/S ratio high or low compared with its own history?
Today's P/S ratio is at or below every one of the 4 fiscal year-ends on record; their median is 78.8×.
What are the highest and lowest P/S ratio figures on record for Mesoblast Limited?
Across the 4 fiscal year-ends on record (2023–2026), the highest was 113.9× in fiscal 2024 and the lowest 14.6× in fiscal 2026.
How is Mesoblast Limited's P/S ratio calculated?
The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Mesoblast Limited it is on record here for 4 fiscal years, 2023 to 2026.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/S ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Mesoblast Limited (MESO) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MESO/ps-ratio
Underlying data: Yahoo Finance.